Disease | proteinuria |
Phenotype | C0011849|diabetes mellitus |
Sentences | 12 |
PubMedID- 21782146 | The prevalence of microalbuminuria and proteinuria in cats with diabetes mellitus. |
PubMedID- 23209764 | The selective vitamin d receptor (vdr) activator, paricalcitol, effectively reduces proteinuria in patients with type 2 diabetes mellitus (t2dm) who have been treated with raas inhibitors [6]. |
PubMedID- 22218118 | Angiotensin receptor blocker and n-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus. |
PubMedID- 23414596 | In addition there were four health states of low gfr chronic kidney disease (ckd: ckd and diabetes mellitus with and without proteinuria and ckd and non-diabetes mellitus with and without proteinuria) and one state of esrd. |
PubMedID- 23544132 | Nevertheless, kubo et al have reported wt1 mrna in whole urine from only 40% (8 in 20) diabetes mellitus patients with proteinuria [19]. |
PubMedID- 21694939 | The incidence of cin is about 11.3% using the definition of a 25% increase in serum creatinine or an absolute increase in serum creatinine of 0.5 mg/dl.56 radiocontrast agents cause aki by inducing renal vasoconstriction followed by hypoxic tubular injury.57,58 predisposing factors include age (>55 years), prior renal insufficiency, diabetes mellitus with neurovascular complications, proteinuria, volume depletion, acute liver failure, and recent nephrotoxic drug exposure.59 the onset of renal failure usually is abrupt within 24 hours after exposure to contrast media and is characterized by oliguria, but it may be nonoliguric.60 recovery of renal function generally occurs. |
PubMedID- 22145829 | Background: proteinuria in patients with diabetes mellitus (dm) is sometimes caused by glomerular diseases other than diabetic nephropathy. |
PubMedID- 24843742 | The purpose of the present study was to emphasize hbv‐associated nephropathy in the differential diagnosis of clinical proteinuria in patients with diabetes mellitus. |
PubMedID- 20425064 | Angiotensin-converting enzyme (ace) inhibitors and angiotensin receptor blockers (arbs) are indispensable therapeutic agents for treating hypertension and proteinuria in patients with diabetes mellitus. |
PubMedID- 23270101 | The addition of spironolactone to the combination of an ace inhibitor, and arb, and a direct renin inhibitor brought about dramatic and sustained reversal of 4-plus proteinuria in a patient with diabetes mellitus and hypertension. |
PubMedID- 25893098 | Monitoring for proteinuria in patients with type 2 diabetes mellitus. |
PubMedID- 20051099 | Specific exclusion criteria for all women enrolled included conception by assisted reproduction, gestational diabetes, diabetes mellitus, a history of smoking and hypertension, proteinuria, renal, cardiovascular hepatic, and endocrine disease, metabolic disorders, and current infection or history of all types of infection. |
Page: 1